Evidence map›Paper›PMID 30186054›Full record

ArticleClinical proteomics2018

Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain,

Sung Ho Yun, Edmond Changkyun Park, Sang-Yeop Lee, Hayoung Lee, Chi-Won Choi, Yoon-Sun Yi, Hyun-Joo Ro, Je Chul Lee, Sangmi Jun, Hye-Yeon Kim and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical proteomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Bacteriophages targetingFrontiers in microbiology · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. OXA β-lactamases frombioRxiv : the preprint server for biology · 2024
    Article
  13. Loss of Lipooligosaccharide Synthesis inInternational journal of molecular sciences · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Sung Ho Yun *1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Edmond Changkyun Park *1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Sang-Yeop Lee1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Hayoung Lee1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Chi-Won ChoiKBNP Technology Institute, KBNP, INC., Anyang, 14059 Republic of Korea.
Yoon-Sun Yi1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Hyun-Joo Ro1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Je Chul Lee5Department of Microbiology, Kyungpook National University School of Medicine, Daegu, 41944 Republic of Korea.
Sangmi Jun1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Hye-Yeon Kim2Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, 34114 Republic of Korea.
Gun-Hwa Kim1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Seung Il Kim1Drug and Disease Target Team, Korea Basic Science Institute, Cheongju, 28119 Republic of Korea.
Korea Basic Science Institute · KRKorea Research Institute of Chemical Technology · KRKorea University of Science and Technology · KRKyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOuter membrane vesicles (OMVs) of

methodsPurified OMVs from

resultsOMV secretion was increased > twofold following imipenem treatment, and cytotoxicity toward A549 human lung carcinoma cells was elevated. A total of 277 proteins were identified as components of OMVs by imipenem treatment, among which β-lactamase OXA-23, various proteases, outer membrane proteins, β-barrel assembly machine proteins, peptidyl-prolyl cis-trans isomerases and inherent prophage head subunit proteins were significantly upregulated.

conclusionIn vitro stress such as antibiotic treatment can modulate proteome components in

Indexed as

Acinetobacter baumanniiModulation by antibiotic treatmentOuter membrane vesiclesProteomics

Identifiers

PMID30186054
PMCPMC6118003
OpenAlexW2889136587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.